Back to Search
CELESTE WILTSE, M.D.
M.D.
General Practice Physician
NPI: 1700928025Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology Physician
Obstetrics & Gynecology
Code: 207V00000X
9900726(NC)
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
9900726(NC)
Research & Publications (15)
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
PMID 19152958·Semin Arthritis Rheum·2010
4-observational
Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
PMID 18625521·J Affect Disord·2009
2-rct
Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
PMID 18204338·J Clin Psychopharmacol·2008
4-observational
Duloxetine in practice-based clinical settings: assessing effects on the emotional and physical symptoms of depression in an open-label, multicenter study.
PMID 17934551·Prim Care Companion J Clin Psychiatry·2007
8-other
The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity.
PMID 17590215·Int J Clin Pract·2007
4-observational
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
PMID 17541049·Am J Psychiatry·2007
4-observational
Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.
PMID 17235383·Prim Care Companion J Clin Psychiatry·2006
8-other
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study.
PMID 16582061·Br J Psychiatry·2006
2-rct
Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.
PMID 15738744·J Clin Psychopharmacol·2005
4-observational
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
PMID 15589385·Eur Neuropsychopharmacol·2004
3-trial
Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine.
PMID 15232330·J Clin Psychopharmacol·2004
3-trial
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).
PMID 14607206·Eur J Heart Fail·2003
3-trial
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure.
PMID 11956122·Circulation·2002
3-trial
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure.
PMID 11167663·Br J Clin Pharmacol·2001
3-trial
The effects of chronic, sustained-release moxonidine therapy on clinical and neurohumoral status in patients with heart failure.
PMID 11077130·Int J Cardiol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 30 TOWN SQUARE BLVD STE 218
ASHEVILLE, NC 28803 - Phone
- (828) 684-1212
Quick Facts
- NPI
- 1700928025
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 15
Are you this provider?
Claim Your Profile